Numis Securities reaffirmed their buy rating on shares of Spire Healthcare Group (LON:SPI) in a research report released on Thursday, Digital Look reports. The firm currently has a GBX 163 ($2.13) price objective on the stock, down from their prior price objective of GBX 280 ($3.66).
Several other equities analysts also recently commented on the company. Peel Hunt reiterated a hold rating on shares of Spire Healthcare Group in a research report on Tuesday, April 2nd. Liberum Capital reiterated a hold rating on shares of Spire Healthcare Group in a research report on Thursday, March 14th. Credit Suisse Group downgraded Spire Healthcare Group to an underperform rating and dropped their target price for the company from GBX 170 ($2.22) to GBX 85 ($1.11) in a research report on Tuesday, February 12th. JPMorgan Chase & Co. reiterated a neutral rating on shares of Spire Healthcare Group in a research report on Wednesday, January 16th. Finally, Barclays dropped their target price on Spire Healthcare Group from GBX 130 ($1.70) to GBX 115 ($1.50) and set an underweight rating for the company in a research report on Friday, April 12th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. The company currently has an average rating of Hold and a consensus target price of GBX 128.75 ($1.68).
Shares of SPI stock opened at GBX 121 ($1.58) on Thursday. The company has a quick ratio of 0.95, a current ratio of 1.44 and a debt-to-equity ratio of 48.52. The firm has a market cap of $485.31 million and a P/E ratio of 43.21. Spire Healthcare Group has a twelve month low of GBX 96.15 ($1.26) and a twelve month high of GBX 259.20 ($3.39).
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Story: Calculate Your Return on Investment (ROI)
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.